IOVA — Iovance Biotherapeutics, Inc. | XLV Holdings | StockAdder

(IOVA)

Iovance Biotherapeutics, Inc.

Live chart and latest IOVA stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

IOVA News

Analyst Sentiment Remains Strong on Iovance Biotherapeutics (IOVA) Amid U.S. Rollout of Melanoma Drug, Amtagvi

Mar 20, 2026 NAI500

A Melanoma Drug Successfully Launched, Yet Iovance’s Stock Has Underperformed the Market for Three Years

Apr 11, 2026 Seeking Alpha

Iovance Biotherapeutics: Positioned For Multi-Year Growth, Buy The Pullback (NASDAQ:IOVA)

Apr 6, 2026 ChartMill

IOVA Earnings History & Surprises | EPS & Revenue Results | IOVANCE BIOTHERAPEUTICS INC (NASDAQ:IOVA)

Apr 10, 2026 Sahm

Iovance Biotherapeutics (IOVA) Is Up 16.9% After Stronger Real-World Amtagvi Data Spurs Franchise Hopes

Apr 11, 2026 Stock Titan

Vanguard (IOVA) shows 0 shares after Jan 12, 2026 realignment

Mar 27, 2026 Yahoo Finance

Is It Time To Reassess Iovance Biotherapeutics (IOVA) After Its Recent Share Price Surge

Mar 26, 2026 Seeking Alpha

Iovance Biotherapeutics: Competition Afoot, But New Indications Can Help (NASDAQ:IOVA)

Mar 31, 2026 Yahoo Finance

Is Iovance Biotherapeutics Inc. (IOVA) One of the Best Immunotherapy Stocks to Buy According to Hedge Funds?

Feb 19, 2026 Yahoo Finance

UBS Raises PT on Iovance Biotherapeutics (IOVA)

Mar 6, 2026 Yahoo Finance

Is It Time To Reconsider Iovance Biotherapeutics (IOVA) After Prolonged Share Price Weakness

Feb 7, 2026 Yahoo Finance

Iovance Biotherapeutics: The High‑Risk Cancer Stock I Think Could Change a Portfolio by 2036

Mar 5, 2026 Yahoo Finance

Iovance (IOVA) Hits 52-Week High as Analyst Doubles Price Target

Mar 6, 2026 Yahoo Finance

Iovance (IOVA) Soars 33%, Hits All-Time High

Mar 7, 2026 Yahoo Finance

Iovance Biotherapeutics, Inc. (IOVA): A Bull Case Theory